Psychiatry & Neurology, Clinical Neurophysiology · Stanford, CA
NPI
1568641736
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
687 services
Medicare patients, 2024
246
Average age 70
Drug cost, 2024
$5.3M
1,210 prescriptions
Company payments, 2025
$33K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srikanth Muppidi was code 99215 (office e&m - established), 124 times for 91 patients. In total Srikanth Muppidi billed 687 services in 27 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 124 | 91 | $119.09 | $15K |
| 99215 Office E&M - Established | Office | 67 | 46 | $150.19 | $10K |
| 95885 Electrical Nerve Conductivity | Facility | 55 | 38 | $16.27 | $895 |
| 99214 Office E&M - Established | Office | 53 | 41 | $116.28 | $6,163 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 47 | $14.69 | $764 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 48 | 41 | $14.98 | $719 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 47 | 33 | $25.83 | $1,214 |
| 99205 Office E&M - New | Facility | 36 | 36 | $136.64 | $4,919 |
| 99214 Office E&M - Established | Facility | 27 | 27 | $72.21 | $1,950 |
| 95923 Electrical Nerve Conductivity | Facility | 23 | 22 | $34.85 | $801 |
| 95924 Electrical Nerve Conductivity | Facility | 21 | 21 | $65.73 | $1,380 |
| 95910 Electrical Nerve Conductivity | Facility | 18 | 18 | $90.48 | $1,629 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $111.05 | $1,444 |
| 95911 Electrical Nerve Conductivity | Facility | 11 | 11 | $119.75 | $1,317 |
By year: 2022 $54K for 630 services; 2023 $49K for 542 services; 2024 $55K for 687 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srikanth Muppidi prescribed most often to Medicare patients was Pyridostigmine Bromide, with 115 prescriptions and refills. In total Srikanth Muppidi wrote 1,210 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 115 | 245 | 38 | $10K |
| Prednisone Generic | 88 | 131 | 22 | $724 |
| Mycophenolate Mofetil Generic | 74 | 126 | 20 | $11K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 67 | 67 | Under 11 | $700K |
| Midodrine Hcl Generic | 62 | 125 | 15 | $3,728 |
| Azathioprine Generic | 56 | 137 | 18 | $6,043 |
| Sodium Chloride 0.9 % Sodium Chloride | 48 | 48 | Under 11 | $1,453 |
| Gabapentin Generic | 48 | 103 | 13 | $756 |
| Diphenhydramine Hcl Generic | 45 | 45 | Under 11 | $717 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 45 | 46 | Under 11 | $428K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 35 | 37 | Under 11 | $251K |
| Mycophenolic Acid Mycophenolate Sodium | 31 | 54 | Under 11 | $29K |
| Vyvgart Efgartigimod Alfa-Fcab | 28 | 33 | Under 11 | $1.3M |
| Vyvgart Hytrulo Efgartigimod-Hyaluronidas-Qvfc | 26 | 26 | Under 11 | $559K |
| Pyridostigmine Bromide Er Pyridostigmine Bromide | 24 | 54 | Under 11 | $13K |
Brand drugs: 332 claims; generic drugs: 878 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srikanth Muppidi $33K ($32K in general payments such as food, travel and fees and $1,001 for research) from 5 companies. The largest payer was Ucb Sa with $17K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.